"⊠She also boosted her price target for Canopy Growth Corporation (CGC) to $82 from $74.
The âwell-capitalized cannabis industry has been evolving rapidlyâ and looks poised to take on a larger total addressable market than originally forecast, Azer wrote in the note. âGiven the nascent stage of global cannabis, we believe that revenue growth should serve as the primary valuation methodology.â
And this revenue growth will come from what she sees as four key verticals: adult use, beauty and nutraceuticals, over-the-counter pain and sleep and pharmaceuticals, she said.
âWe believe that all four of these verticals represent large market opportunities,â she said. Consumer industry veterans âare beginning to embrace the broad market potential for cannabis as a global, multi-dimensional category, given the talent migration to cannabis.â







